Zydus, Lupin sign pact to co-market weight-loss Semaglutide injection in India

Zydus Lifesciences and Lupin have joined forces to bring Semaglutide Injection to India. This medication helps manage type 2 diabetes and aids in chronic weight management. This collaboration aims to provide advanced therapies for metabolic disorders across the nation.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/KkhBqjl
via IFTTT

0 comments:

Post a Comment